Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Bally

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|January 1, 1997
Plasma clearance, biodistribution and therapeutic properties of mitoxantrone encapsulated in conventional and sterically stabilized liposomes after intravenous administration in BDF1 miceC W Chang, L Barber, C Ouyang, et al.
Biophysical Journal|August 1, 1989
Proton flux in large unilamellar vesicles in response to membrane potentials and pH gradientsT E Redelmeier, L D Mayer, K F Wong, et al.
Biochimica Et Biophysica Acta|September 21, 1990
Protein-liposome conjugates with defined size distributionsH C Loughrey, K F Wong, L S Choi, et al.
Biochemistry|October 3, 1995
Formation of novel hydrophobic complexes between cationic lipids and plasmid DNAD L Reimer, Y Zhang, S Kong, et al.
Biochimica Et Biophysica Acta|March 30, 1990
Liposomes with entrapped doxorubicin exhibit extended blood residence timesM B Bally, R Nayar, D Masin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 18, 2011
Irinophore C™, a lipid-based nanoparticulate formulation of irinotecan, is more effective than free irinotecan when used to treat an orthotopic glioblastoma modelM Verreault, D Strutt, D Masin, et al.
Methods in Molecular Medicine|February 15, 2011
15 targeted gene transfer : a practical guide based on experience with lipid-based plasmid delivery systemsE K Wasan, D L Reimer, P Harvie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Eradication of human non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamideR J Klasa, M B Bally, R Ng, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregatesD L Reimer, S Kong, M Monck, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemiaL D Mayer, R Nayar, R L Thies, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|January 1, 1997
Plasma clearance, biodistribution and therapeutic properties of mitoxantrone encapsulated in conventional and sterically stabilized liposomes after intravenous administration in BDF1 miceC W Chang, L Barber, C Ouyang, et al.
Biophysical Journal|August 1, 1989
Proton flux in large unilamellar vesicles in response to membrane potentials and pH gradientsT E Redelmeier, L D Mayer, K F Wong, et al.
Biochimica Et Biophysica Acta|September 21, 1990
Protein-liposome conjugates with defined size distributionsH C Loughrey, K F Wong, L S Choi, et al.
Biochemistry|October 3, 1995
Formation of novel hydrophobic complexes between cationic lipids and plasmid DNAD L Reimer, Y Zhang, S Kong, et al.
Biochimica Et Biophysica Acta|March 30, 1990
Liposomes with entrapped doxorubicin exhibit extended blood residence timesM B Bally, R Nayar, D Masin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 18, 2011
Irinophore C™, a lipid-based nanoparticulate formulation of irinotecan, is more effective than free irinotecan when used to treat an orthotopic glioblastoma modelM Verreault, D Strutt, D Masin, et al.
Methods in Molecular Medicine|February 15, 2011
15 targeted gene transfer : a practical guide based on experience with lipid-based plasmid delivery systemsE K Wasan, D L Reimer, P Harvie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Eradication of human non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamideR J Klasa, M B Bally, R Ng, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregatesD L Reimer, S Kong, M Monck, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemiaL D Mayer, R Nayar, R L Thies, et al.
Pageof 10